BioSpace News Archive

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that it is nearing the previously-announced expiration date for its rights offering of 5:00 pm Eastern Time on March 1, 2023 (the “Expiration Date”).

Theralink Technologies, a precision oncology company with a novel phosphoprotein-based assay for advanced breast cancer, announced that the Company has begun receiving payments from third party payors for its advanced breast cancer assay.

Jaguar Health, Inc. today announced that the Company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for U.S. Patent Application No. 16/617,466, titled Methods And Compositions For Treating Bile Acid Diarrhea.

Neuronetics, Inc., a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced its first of several TrakStar® Patient Data Management System software releases this year.

Movano Inc. (NASDAQ: MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it will report fourth quarter 2022 financial and operating results on Monday, March 20, 2023.

Tivic Health® Systems, Inc. announced it has received recertification of ISO 13485, the international standard for medical device quality systems.

Waters Corporation Udit Batra Ph.D., Waters’ President and Chief Executive Officer, will participate in a fireside chat at the Cowen Healthcare Conference on Monday, March 6th, 2023 at 9:50AM Eastern Time.

In a review article recently published in Vaccines Journal, Dr. Carmen Ledesma-Feliciano, Scientific Affairs Manager at PharmaJet, referencing over 25 studies, discusses multiple injection delivery methods including PharmaJet’s needle-free precision delivery systems, which enhance the clinical performance of DNA-based vaccines.

Median Technologies (Paris:ALMDT), will be participating in the Cowen’s 43rd Annual Health Care Conference, taking place on March 6 – 8 ,2023, at the Boston Marriott Copley Place in Boston, MA, USA.

Convatec today announced it has received clearance from the U.S. Food and Drug Administration for its InnovaMatrix® PD particulate placental extracellular matrix medical device for wound management.